Your session is about to expire
← Back to Search
Decision Aid for Lung Cancer
Study Summary
This trial is testing a decision aid to help patients with non-small cell lung cancer make better decisions about their care. The goal is to improve patient involvement, satisfaction, and communication with their physician.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am being tested for suspected lung cancer at any stage.You are expected to live for at least 6 more months.I have completed treatment for early or advanced non-small cell lung cancer.You have a high score on a test for memory and thinking problems.
- Group 1: Arm I (conversation tool)
- Group 2: Arm II (usual care)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers seeking new participants for this investigation?
"Affirmative. Clinicaltrials.gov confirms that this medical study, originally posted on August 7th 2020, is actively welcoming new patients to participate. Around 100 participants will be accepted at two separate sites of research."
What is the enrolment tally for this research endeavor?
"Affirmative, the clinicaltrials.gov portal indicates that this research initiative is actively recruiting participants. This trial was first posted on August 7th 2020 and revised most recently on June 8th 2022; they are still in need of 100 individuals across two sites."
What is the primary objective of this medical research endeavor?
"The main metric of measurement during this trial is the operational feasibility of a conversation tool. Secondary outcomes include decisional conflict (measured through Decisional Conflict Scale), patient involvement in treatment decisions (through Control Preferences Scale) and values-treatment concordance (assessed via Electronic Medical Record)."
Share this study with friends
Copy Link
Messenger